NO980929D0 - Nye benzoksazindionderivater, fremgangsmåte for deres fremstilling og deres anvendelse - Google Patents

Nye benzoksazindionderivater, fremgangsmåte for deres fremstilling og deres anvendelse

Info

Publication number
NO980929D0
NO980929D0 NO980929A NO980929A NO980929D0 NO 980929 D0 NO980929 D0 NO 980929D0 NO 980929 A NO980929 A NO 980929A NO 980929 A NO980929 A NO 980929A NO 980929 D0 NO980929 D0 NO 980929D0
Authority
NO
Norway
Prior art keywords
preparation
dione derivatives
benzoxazine dione
new
new benzoxazine
Prior art date
Application number
NO980929A
Other languages
English (en)
Other versions
NO310657B1 (no
NO980929L (no
Inventor
Lothar Heinisch
Steffen Wittmann
Ute Moellmann
Rolf Reissbrodt
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of NO980929D0 publication Critical patent/NO980929D0/no
Publication of NO980929L publication Critical patent/NO980929L/no
Publication of NO310657B1 publication Critical patent/NO310657B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26Two oxygen atoms, e.g. isatoic anhydride
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO19980929A 1997-03-05 1998-03-04 Nye benzoksazindionderivater og deres anvendelse NO310657B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19708846A DE19708846A1 (de) 1997-03-05 1997-03-05 Neue Benzoxazindionderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (3)

Publication Number Publication Date
NO980929D0 true NO980929D0 (no) 1998-03-04
NO980929L NO980929L (no) 1998-09-07
NO310657B1 NO310657B1 (no) 2001-08-06

Family

ID=7822233

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19980929A NO310657B1 (no) 1997-03-05 1998-03-04 Nye benzoksazindionderivater og deres anvendelse

Country Status (30)

Country Link
US (1) US6013647A (no)
EP (1) EP0863139B1 (no)
JP (1) JPH10316666A (no)
KR (1) KR19980079905A (no)
CN (1) CN1075064C (no)
AR (1) AR010125A1 (no)
AT (1) ATE200080T1 (no)
AU (1) AU737760B2 (no)
BR (1) BR9802894A (no)
CA (1) CA2230965A1 (no)
CO (1) CO4950613A1 (no)
CZ (1) CZ65098A3 (no)
DE (2) DE19708846A1 (no)
DK (1) DK0863139T3 (no)
ES (1) ES2157617T3 (no)
GR (1) GR3035834T3 (no)
HK (1) HK1015763A1 (no)
HU (1) HUP9800472A3 (no)
IL (1) IL123535A (no)
NO (1) NO310657B1 (no)
NZ (1) NZ329883A (no)
PE (1) PE71799A1 (no)
PL (1) PL325142A1 (no)
PT (1) PT863139E (no)
RU (1) RU2184114C2 (no)
SI (1) SI0863139T1 (no)
SK (1) SK28898A3 (no)
UA (1) UA45414C2 (no)
UY (1) UY24915A1 (no)
ZA (1) ZA981847B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6115157A (en) * 1997-12-24 2000-09-05 Nortel Networks Corporation Methods for equalizing WDM systems
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
DE10111164A1 (de) * 2001-03-01 2002-09-05 Gruenenthal Gmbh Neue substituierte Catecholderivate abgeleitet von mehrbasischen sekundären Aminosäuren, Verfahren zu ihrer Herstellung und ihre Anwendung
US7595073B2 (en) * 2003-02-28 2009-09-29 Kraft Foods Global Brands Llc Use of siderophores and organic acids to retard lipid oxidation
US20040186087A1 (en) * 2003-03-20 2004-09-23 Ceramoptec Industries, Inc. Siderophore conjugates of photoactive dyes for photodynamic therapy
EP1888574B1 (en) * 2005-05-25 2009-09-02 Actelion Pharmaceuticals Ltd. New antibiotic derivatives
TWI603962B (zh) * 2016-09-10 2017-11-01 國立清華大學 含硫噁嗪化合物及其合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047573A (en) * 1962-07-31 N-alkylamido substituted
FR831710A (fr) * 1937-02-02 1938-09-13 Procédé de fabrication de fermetures à tirette, à partir de matière non métallique
DE1147583B (de) * 1959-07-01 1963-04-25 Nippon Shinyaku Co Ltd Verfahren zur Herstellung von 2, 4-Dioxo-dihydro-1, 3-benzoxazinyl-(3)-essigsaeure-dialkylamiden
GB878603A (en) * 1959-07-01 1961-10-04 Nippon Shinyaku Co Ltd Salicyclic acid derivatives
US4338436A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl)amino]acetamido]cephalosporins
US4319028A (en) * 1976-08-26 1982-03-09 Eli Lilly And Company 7-(2-(Substituted benzoyl)amino)acetamido)cephalosporins
US4338439A (en) * 1976-08-26 1982-07-06 Eli Lilly And Company 7-[2-[(Substituted benzoyl]amino]acetamido]cephalosporins
GB8811055D0 (en) * 1988-05-10 1988-06-15 Ici Plc Antibiotic compounds
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
DE4102234A1 (de) * 1991-01-23 1992-07-30 Dresden Arzneimittel Neue (alpha)-aminochinolinoyl-(3)-penicilline, verfahren zu deren herstellung und diese enthaltende antibakterielle mittel
IT1256023B (it) * 1992-06-10 1995-11-20 Italfarmaco Spa Derivati benzossazinonici e benzotiazinonici ad attivita' cardiovascolare
DE19654920A1 (de) * 1996-06-26 1998-01-08 Gruenenthal Gmbh Neue synthetische Catecholderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
HUP9800472A2 (hu) 1999-06-28
PT863139E (pt) 2001-07-31
JPH10316666A (ja) 1998-12-02
CN1195664A (zh) 1998-10-14
CN1075064C (zh) 2001-11-21
HK1015763A1 (en) 1999-10-22
SI0863139T1 (en) 2001-06-30
HUP9800472A3 (en) 2000-09-28
ES2157617T3 (es) 2001-08-16
PL325142A1 (en) 1998-09-14
NO310657B1 (no) 2001-08-06
UA45414C2 (uk) 2002-04-15
NO980929L (no) 1998-09-07
US6013647A (en) 2000-01-11
NZ329883A (en) 1999-04-29
AU5645598A (en) 1998-09-10
DE19708846A1 (de) 1998-09-17
IL123535A0 (en) 1998-10-30
KR19980079905A (ko) 1998-11-25
CZ65098A3 (cs) 1998-09-16
ZA981847B (en) 1998-09-08
CO4950613A1 (es) 2000-09-01
GR3035834T3 (en) 2001-08-31
EP0863139A1 (de) 1998-09-09
AU737760B2 (en) 2001-08-30
ATE200080T1 (de) 2001-04-15
CA2230965A1 (en) 1998-09-05
AR010125A1 (es) 2000-05-17
PE71799A1 (es) 1999-08-07
UY24915A1 (es) 2000-12-29
DE59800568D1 (de) 2001-05-03
IL123535A (en) 2000-10-31
BR9802894A (pt) 2000-03-21
HU9800472D0 (en) 1998-04-28
EP0863139B1 (de) 2001-03-28
SK28898A3 (en) 1998-11-04
DK0863139T3 (da) 2001-04-30
RU2184114C2 (ru) 2002-06-27

Similar Documents

Publication Publication Date Title
NO980720D0 (no) Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
NO975710L (no) Nye Dolastatinderivater, deres fremstilling og anvendelse
NO20015113L (no) Nye forbindelser, deres fremstilling og anvendelse
NO954942D0 (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og anvendelse av derivatene som legemidler
NO964654L (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
NO963506D0 (no) 4-Heterocyklyl-substituerte kinazolin-derivater, fremgangsmåte for fremstilling derav og deres anvendelse som anti-kreftmidler
EE200100437A (et) C-21 modifitseeritud epotioloonid, nende valmistamise meetod ning kasutamine
NO954369L (no) Oksazolidindionderivater, deres fremstilling og anvendelse
NO991761D0 (no) Nye piperidin-kotokarbonsyre-derivater, deres fremstilling og anvendelse
DK0885234T3 (da) Nye erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO984717D0 (no) Nye hydroksamsyre-derivater, deres fremstilling og anvendelse
NO985307L (no) Distamycinderivater, fremgangsmÕte for deres fremstilling, og deres anvende
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO984714L (no) Nye karboksylsyre-derivater, deres fremstilling og anvendelse
NO20001934D0 (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
NO984713L (no) Nye karboksylsyre-derivater, deres fremstilling og anvendelse
DK0701554T3 (da) Benzisoselen-azolinderivater og -azinderivater, fremgangsmåde til fremstilling heraf og deres terapeutiske anvendelse
NO980929D0 (no) Nye benzoksazindionderivater, fremgangsmåte for deres fremstilling og deres anvendelse
DK0835254T3 (da) Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse
NO984624L (no) Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav
NO971424D0 (no) Nye heterocyklisk substituerte imidazolo-kinoksalidoner, deres fremstilling og anvendelse
NO955242D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse
NO992859D0 (no) Nye derivater av erytromycin, fremgangsmÕte for fremstilling av disse og deres anvendelse som medikamenter
NO991622D0 (no) Nye derivater av pentaerytritt, deres fremstilling og anvendelse sÕvel som mellomprodukt for syntese av det samme
NO20023188L (no) Nye heteroarylderivater, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees